HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,243 | -34.2% | 17,712 | -25.9% | 0.00% | – |
| Q2 2023 | $27,736 | -28.1% | 23,910 | -6.4% | 0.00% | – |
| Q1 2023 | $38,584 | -56.6% | 25,552 | +20.5% | 0.00% | -100.0% |
| Q3 2022 | $89,000 | +4350.0% | 21,198 | +3638.6% | 0.00% | – |
| Q2 2022 | $2,000 | -66.7% | 567 | -47.7% | 0.00% | – |
| Q1 2022 | $6,000 | +20.0% | 1,085 | +108.3% | 0.00% | – |
| Q4 2021 | $5,000 | -50.0% | 521 | -41.5% | 0.00% | – |
| Q3 2021 | $10,000 | -33.3% | 891 | -10.4% | 0.00% | – |
| Q2 2021 | $15,000 | +87.5% | 994 | +102.9% | 0.00% | – |
| Q1 2021 | $8,000 | +300.0% | 490 | +390.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | -33.3% | 100 | -50.0% | 0.00% | – |
| Q2 2020 | $3,000 | -88.5% | 200 | -85.7% | 0.00% | -100.0% |
| Q3 2019 | $26,000 | +550.0% | 1,396 | +598.0% | 0.00% | – |
| Q2 2019 | $4,000 | -20.0% | 200 | 0.0% | 0.00% | – |
| Q1 2019 | $5,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -16.7% | 200 | 0.0% | 0.00% | – |
| Q3 2018 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|